文献速递血液净化与透析

导管改道术联合出口处重建可提高腹膜透析导管存活率

Catheter Diversion Procedure With Exit-Site Renewal Promotes Peritoneal Dialysis Catheter Survival.
PubMed 文献 · Kidney Int Rep · 2020-12-07

该回顾性研究纳入2001-2019年148例腹膜透析患者,其中33例因出口处感染或隧道感染行导管改道术(CDP),115例接受保守治疗或无治疗。

要点

  • CDP后30天和90天无感染率分别为90%和67%。
  • CDP与透析终止或死亡独立相关(HR 0.44,95%CI 0.24-0.80)。

核心结论

  • CDP可能提高腹膜透析导管存活率,是治疗出口处感染/隧道感染的有效且创伤较小的手术方法,可避免撤除腹膜透析。

研究设计与样本

  • 回顾性研究,纳入2001-2019年148例开始腹膜透析的患者,33例因出口处感染/隧道感染行CDP(CDP组),115例接受保守治疗或无治疗(非CDP组),并设虚拟撤管组。

主要发现

  • CDP后30天和90天无感染率分别为90%和67%。
  • 多因素分析显示血清白蛋白浓度(HR 0.33,95%CI 0.17-0.67)、腹膜透析+血液透析联合治疗(HR 0.29,95%CI 0.17-0.49)和CDP(HR 0.44,95%CI 0.24-0.80)与透析终止或死亡独立相关。

临床怎么用

  • 对于腹膜透析合并出口处感染/隧道感染的患者,可考虑行导管改道术联合出口处重建以挽救导管,避免撤管。

局限性

  • 本研究为单中心回顾性研究,样本量有限,CDP组仅33例,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Catheter-related infections such as exit site infection (ESI) and tunnel infection (TI) are major causes of peritoneal dialysis (PD) discontinuation. For ESI/TI treatment, catheter diversion procedure (CDP) with exit-site renewal for catheter salvage presents an alternative to catheter removal. Nevertheless, CDP capability of improving PD catheter survival remains unclear. METHODS: We retrospectively reviewed our hospital patients who started PD during 2001-2019 (n=148): 33 treated for ESI/TI by CDP (CDP group) and 115 treated for ESI/TI using conservative therapy or none (non-CDP group). A "virtual discontinuation group" was designated for patients in the CDP group who had received PD catheter removal instead of CDP and who had stopped PD. Kaplan-Meier analysis and log-rank test PD were used for intergroup catheter survival comparison. Associations between clinical factors and PD discontinuation or death were examined using Cox proportional hazards regression analyses. RESULTS: For patients (76% male, mean age of 61.7±13.0 years), 40 CDP were performed for 33 CDP group patients. Infection-free rates at 30 and 90 days after CDP were, respectively, 90% and 67%. The CDP group PD catheter survival rate was significantly higher than that of virtual discontinuation group (P < .01) and higher than that of the non-CDP group (P = .03). Multivariate analysis revealed independent association of serum albumin concentration (hazard ratio 0.33, 95% confidence interval 0.17-0.67), PD+HD combination therapy (hazard ratio 0.29, 95% confidence interval 0.17-0.49), and CDP (hazard ratio 0.44, 95% confidence interval 0.24-0.80) with PD discontinuation or death. CONCLUSION: Results show that CDP may improve PD catheter survival as an effective and less-invasive surgical treatment for ESI/TI to avoid withdrawal of PD.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Oki R, Hamasaki Y, Komaru Y, et al. Catheter Diversion Procedure With Exit-Site Renewal Promotes Peritoneal Dialysis Catheter Survival. Kidney Int Rep. 2020. PMID: 33615057. doi:10.1016/j.ekir.2020.11.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。